• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    The Pennant Group Announces Pricing of Public Offering of Common Stock

    10/2/24 8:34:17 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care
    Get the next $PNTG alert in real time by email

    EAGLE, Idaho, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG) (the "Company") today announced the pricing of an underwritten public offering of 3,500,000 shares of its common stock at a public offering price of $31.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $108.5 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 525,000 shares of common stock. The Company expects to use the net proceeds from the offering to repay outstanding indebtedness under the Company's revolving credit facility and any remaining for general corporate purposes. The offering is expected to close on or about October 4, 2024, subject to customary closing conditions.

    Citigroup and Truist Securities are acting as the lead book-running managers for the offering. Wells Fargo Securities and RBC Capital Markets are acting as joint book-running managers. Oppenheimer & Co. and Stephens Inc. are acting as co-managers. The offering of the common stock is being made pursuant to the Company's effective shelf registration statement filed with the Securities and Exchange Commission (the "SEC"). A preliminary prospectus supplement and accompanying prospectus relating to and describing the terms of the offering was filed with the SEC on September 30, 2024. The final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC. When available, a copy of the prospectus supplement and accompanying prospectus relating to the offering may be obtained from: Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by telephone at (800) 831-9146; and Truist Securities, Inc., Attention: Prospectus Department, 3333 Peachtree Road NE, 9th Floor, Atlanta, GA 30326, by telephone at (800) 685-4786, or by email at [email protected].

    This press release does not constitute an offer to sell or the solicitation of an offer to buy nor will there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    About The Pennant Group, Inc.

    The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 117 home health and hospice agencies and 54 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets.

    Forward-Looking Statements

    This press release contains forward-looking statements that are based on management's current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events, made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding future events, including the completion and timing of the offering, the gross proceeds expected to be received from the offering and the anticipated use of the net proceeds from the offering. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement. These risks and uncertainties relate to fluctuations in the Company's stock price, changes in market conditions and satisfaction of customary closing conditions related to the public offering, as well as the other factors discussed in the "Risk Factors" section in the prospectus supplement and registration statement referenced above and in the Company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, as well as other risks detailed in the Company's filings with the SEC. All information in this press release is as of the date of the release and should not be relied upon as representing its views as of any subsequent date. Except as required by the federal securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

    Contact Information

    Investor Relations

    The Pennant Group, Inc.

    (208) 506-6100

    [email protected]

    SOURCE: The Pennant Group, Inc.



    Primary Logo

    Get the next $PNTG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PNTG

    DatePrice TargetRatingAnalyst
    12/8/2025Outperform
    William Blair
    12/2/2025$34.00Hold → Buy
    Truist
    11/18/2025$31.00Equal Weight → Overweight
    Wells Fargo
    10/24/2025$30.00Buy
    Jefferies
    12/19/2024$33.00Equal Weight
    Wells Fargo
    1/5/2024$14.00 → $18.00Equal-Weight → Overweight
    Stephens
    2/27/2023$15.00 → $16.00Hold → Buy
    Stifel
    8/25/2022$22.00Outperform
    Oppenheimer
    More analyst ratings

    $PNTG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Pennant Group

    William Blair initiated coverage of Pennant Group with a rating of Outperform

    12/8/25 8:35:42 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Group upgraded by Truist with a new price target

    Truist upgraded Pennant Group from Hold to Buy and set a new price target of $34.00

    12/2/25 8:17:55 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Group upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Pennant Group from Equal Weight to Overweight and set a new price target of $31.00

    11/18/25 8:16:18 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    SEC Filings

    View All

    SEC Form DEF 14A filed by The Pennant Group Inc.

    DEF 14A - Pennant Group, Inc. (0001766400) (Filer)

    3/31/26 4:05:46 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by The Pennant Group Inc.

    SCHEDULE 13G/A - Pennant Group, Inc. (0001766400) (Subject)

    3/27/26 11:22:49 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    SEC Form 10-K filed by The Pennant Group Inc.

    10-K - Pennant Group, Inc. (0001766400) (Filer)

    2/26/26 8:05:00 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Walbom Lynette was granted 14,292 shares, increasing direct ownership by 537% to 16,955 units (SEC Form 4)

    4 - Pennant Group, Inc. (0001766400) (Issuer)

    3/12/26 3:14:14 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    EVP, GC and Corp Secy Cheney Kirk Sterling was granted 4,085 shares, increasing direct ownership by 24% to 21,005 units (SEC Form 4)

    4 - Pennant Group, Inc. (0001766400) (Issuer)

    3/12/26 3:14:27 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Chief Operating Officer Gochnour John J was granted 18,565 shares, increasing direct ownership by 14% to 152,815 units (SEC Form 4)

    4 - Pennant Group, Inc. (0001766400) (Issuer)

    3/12/26 3:14:20 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pennant Acquires Arbor Rose Senior Living Community in Mesa, Arizona

    EAGLE, Idaho, April 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced the acquisition of the real estate and operations of Arbor Rose Senior Living, an established senior living community located in Mesa, Arizona, which will now be known as Lavender Lane Senior Living. The Lavender Lane campus includes independent living, assisted living, and memory care services, with 74 licensed beds comprised of 44 assisted living beds and 30 memory care beds, in addition to 25 independent living units. The acquisition strengthens Pennant's Arizona senior

    4/1/26 4:53:32 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    UPDATE – Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference

    EAGLE, Idaho, March 17, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Oppenheimer Co. Annual Healthcare MedTech & Services Conference on March 18, 2026.  Brent Guerisoli, Chief Executive Officer, and Lynette Walbom, Chief Financial Officer will participate in a fireside chat on March 18, 2026 at 10:40 a.m. Eastern Time. A live webcast of the event will be accessible at the following address:investor.pennantgroup.com/events-and-presentations. About Pennant The Pennant Group, Inc. is a holding company of ind

    3/17/26 1:40:17 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference

    EAGLE, Idaho, March 16, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Oppenheimer Co. Annual Healthcare MedTech & Services Conference on March 18, 2026. Brent Guerisoli, Chief Executive Officer, and Lynette Walbom, Chief Financial Officer will participate in a fireside chat on March 18, 2026 at 9:40 a.m. Eastern Time. A live webcast of the event will be accessible at the following address:investor.pennantgroup.com/events-and-presentations. About Pennant The Pennant Group, Inc. is a holding company of indep

    3/16/26 6:15:25 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Leadership Updates

    Live Leadership Updates

    View All

    The Pennant Group Appoints Suzanne Snapper as Director

    EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company's annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. ("Ensign") (NASDAQ:ENSG), a leading publicly-traded provider of skilled nursing services. In this role, which Ms. Snapper has held since 2009, Ms. Snapper is responsible for Ensign's accounting, finance, information technology, tax, internal contro

    5/16/25 12:12:47 PM ET
    $ENSG
    $PNTG
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services

    The Pennant Group Appoints Brent Guerisoli as Chairman and Scott Lamb as Lead Independent Director

    EAGLE, Idaho, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, and senior living companies, today announced the appointment of Brent Guerisoli as Chairman of its board of directors and Scott Lamb as Lead Independent Director of its board of directors, each effective January 1, 2025. Mr. Guerisoli and Mr. Lamb are existing directors of the Company. Mr. Guerisoli has served on Pennant's board since 2023. He has been a key leader with the organization since 2012 and has served as its Chief Executive Officer since 2022. Mr. Guerisoli succeeds Barry Smith, who served as Chairman since February 2

    1/2/25 4:23:29 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    The Pennant Group Appoints Lynette Walbom as Chief Financial Officer

    EAGLE, Idaho, May 22, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that its Board of Directors has appointed Lynette Walbom as Chief Financial Officer effective May 22, 2023. Before joining Pennant, Ms. Walbom was Vice President of Financial Reporting & Tax for Raising Cane's Restaurants, LLC, a national restaurant chain operating in 35 states, which more than doubled in size—based on number of restaurants and geographic footprint—during her tenure. At Raising Cane's, Ms. Walbom had broad responsibility for financial reporting, acquisitions, tax, accou

    5/22/23 4:05:00 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Financials

    Live finance-specific insights

    View All

    Pennant Acquires Arbor Rose Senior Living Community in Mesa, Arizona

    EAGLE, Idaho, April 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced the acquisition of the real estate and operations of Arbor Rose Senior Living, an established senior living community located in Mesa, Arizona, which will now be known as Lavender Lane Senior Living. The Lavender Lane campus includes independent living, assisted living, and memory care services, with 74 licensed beds comprised of 44 assisted living beds and 30 memory care beds, in addition to 25 independent living units. The acquisition strengthens Pennant's Arizona senior

    4/1/26 4:53:32 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Reports Fourth Quarter and Fiscal Year 2025 Results

    EAGLE, Idaho, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.84 for the full year and $0.24 for the fourth quarter of 2025. Pennant also reported adjusted diluted earnings per share of $1.18 for the full year and $0.34 for the quarter(1). Fourth Quarter Highlights Total revenue for the full year was $947.7 million, an increase of $252.5 million or 36.3% over the prior year, and for the quarter was $289.3 million, an increase of $100.4 million or 53.2% over the prior year qua

    2/25/26 4:25:00 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Reports Third Quarter 2025 Results

    EAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.17 for the third quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.30 for the quarter(1). Third Quarter Highlights Total revenue for the third quarter was $229.0 million, an increase of $48.4 million or 26.8% over the prior year quarter;Net income for the third quarter was $6.1 million, a decrease of $0.1 million or 2.0% over the prior year quarter;Adjusted net income for the third qu

    11/5/25 4:05:00 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

    SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

    11/14/24 1:28:33 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

    SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

    11/7/24 9:30:29 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by The Pennant Group Inc.

    SC 13G - Pennant Group, Inc. (0001766400) (Subject)

    11/7/24 9:12:22 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care